Peña, K.B.;                     Riu, F.;                     Hernandez, A.;                     Guilarte, C.;                     Badia, J.;                     Parada, D.    
        Usefulness of the Urine Methylation Test (Bladder EpiCheck®) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells—An Institutional Study. J. Clin. Med. 2022, 11, 3855.
    https://doi.org/10.3390/jcm11133855
    AMA Style
    
                                Peña KB,                                 Riu F,                                 Hernandez A,                                 Guilarte C,                                 Badia J,                                 Parada D.        
                Usefulness of the Urine Methylation Test (Bladder EpiCheck®) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells—An Institutional Study. Journal of Clinical Medicine. 2022; 11(13):3855.
        https://doi.org/10.3390/jcm11133855
    
    Chicago/Turabian Style
    
                                Peña, Karla B.,                                 Francesc Riu,                                 Anna Hernandez,                                 Carmen Guilarte,                                 Joan Badia,                                 and David Parada.        
                2022. "Usefulness of the Urine Methylation Test (Bladder EpiCheck®) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells—An Institutional Study" Journal of Clinical Medicine 11, no. 13: 3855.
        https://doi.org/10.3390/jcm11133855
    
    APA Style
    
                                Peña, K. B.,                                 Riu, F.,                                 Hernandez, A.,                                 Guilarte, C.,                                 Badia, J.,                                 & Parada, D.        
        
        (2022). Usefulness of the Urine Methylation Test (Bladder EpiCheck®) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells—An Institutional Study. Journal of Clinical Medicine, 11(13), 3855.
        https://doi.org/10.3390/jcm11133855